Heartsciences provides business update and reports first quarter of fiscal 2026 financial results

Southlake, tx, sept. 11, 2025 (globe newswire) -- heartsciences inc. (nasdaq: hscs; hscsw) ("heartsciences" or the "company"), an artificial intelligence (“ai”)-powered medical technology company transforming ecgs/ekgs to enable earlier detection of heart disease, today announced its financial results for the first quarter of fiscal 2026 ended july 31, 2025 (“fq1 2026”) and provided a business update highlighting continued progress.
HSCS Ratings Summary
HSCS Quant Ranking